Level Bio AB logo

Level Bio AB (4MB)

Market Open
12 Aug, 06:04
XFRA XFRA
0. 01
+0
+14.2857%
2.18M Market Cap
- P/E Ratio
- Div Yield
4,000 Volume
- Eps
0.01
Previous Close
Add Transaction
Day Range
0.01 0.01
Year Range
0.01 0.03
Want to track 4MB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4MB trading today higher at €0.01, an increase of 14.2857% from yesterday's close, completing a monthly decrease of -11.1111% or €0. Over the past 12 months, 4MB stock lost -31.4286%.
4MB is not paying dividends to its shareholders.
The last earnings report, released on Apr 18, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

4MB Chart

People also search for

ZC0
Stainless Tankers ASA
3.65
-6.1697%
KRY
Glaston Oyj Abp
1.04
+0.4808%
Z9H
Erredue S.p.A.
10.2
0%
DKC
Asia Tele-Net and Technology Corporation Limited
0.47
-11.3207%
4C4
New Amsterdam Invest N.V.
8.5
-2.2989%

Level Bio AB (4MB) FAQ

What is the stock price today?

The current price is €0.01.

On which exchange is it traded?

Level Bio AB is listed on XFRA.

What is its stock symbol?

The ticker symbol is 4MB.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.18M.

Has Level Bio AB ever had a stock split?

No, there has never been a stock split.

Level Bio AB Profile

Professional Services Industry
Industrials Sector
Mr. Joakim Granemo CEO
XFRA Exchange
SE0000885501 ISIN
DE Country
13 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Level Bio AB, formerly known as AlphaHelix Molecular Diagnostics AB, is a company that undertakes the design, development, and international distribution of diagnostic products, specializing in the Nordic region. Founded in 1998 and headquartered in Stockholm, Sweden, Level Bio AB focuses on delivering high-quality equipment, consumables, and reagents for molecular biology, alongside research and diagnostic products primarily in Sweden and the Nordic countries. Its mission extends to developing advanced diagnostic solutions for genetic fetal diagnostics as well as tackling challenges related to genetic miscarriage and infertility. Furthermore, Level Bio is committed to innovation in congenital heart defect diagnostics. The name change to Level Bio AB took effect in May 2024, marking a new phase in the company's evolution while continuing its tradition of excellence and innovation in the field of molecular diagnostics.

Products and Services

  • Rob - An automated 96/384 qPCR setup designed for high-throughput and precise quantitative PCR analyses. Rob revolutionizes molecular biology protocols by providing a reliable, fast, and efficient method of conducting large-scale quantitative PCR assays, thus enhancing research and diagnostic workflows.
  • BugScreener - A diagnostic system specifically designed for the screening of methicillin-resistant Staphylococcus aureus (MRSA). This innovative tool addresses the critical need for rapid, accurate, and efficient screening of MRSA, a major concern in hospital settings and community health due to its antibiotic resistance.
  • aAmp - A state-of-the-art thermal cycler utilizing the proprietary SuperConvection technology. This technology enables highly accurate PCR assays by optimizing the cycling conditions to improve the efficiency and reliability of PCR reactions. The aAmp thermal cycler is an indispensable tool for researchers and clinicians who demand precision and reliability in their genetic diagnostics and research.

Contact Information

Address: VAestra FinnbodavAegen 4B, Stockholm, Sweden, 131 30
Phone: 46 86 26 76 00